yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q43682843-066DF4D3-2A90-4B72-8437-50083E34FDE3
Q43682843-066DF4D3-2A90-4B72-8437-50083E34FDE3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43682843-066DF4D3-2A90-4B72-8437-50083E34FDE3
Differences in survival for patients with metastatic colorectal cancer by lines of treatment received and stage at original diagnosis.
P2860
Q43682843-066DF4D3-2A90-4B72-8437-50083E34FDE3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43682843-066DF4D3-2A90-4B72-8437-50083E34FDE3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c50f27141de02217216c160282212807d52c3693
P2860
The continuation of bevacizumab following disease progression in patients with metastatic colorectal cancer offers a survival benefit.